Partnership
L'attività di ricerca dei dottorandi è approfondita e sviluppata anche attraverso la collaborazione con strutture di ricerca di rilevanza nazionale ed internazionale.
Il curriculum in Scienze Farmaceutiche ha attualmente le seguenti convenzioni nazionali ed internazionali:
- Institute for Experimental Oncology, Freiburg (Germania);
- University of Nottingham (UK);
- Istituto Nazionale dei Tumori Milano;
- School of Pharmacy – University of Cardiff (UK);
- School of Pharmacy – University of London (UK);
- Semmelweis University – Budapest, Hungary; Pazmany Peter Catholic University – Budapest, Hungary;
- Université de Lyon, France;
- Institut des Biomolécules Max Mousseron CNRS UMR 5247, UFR Pharmacie - Université Montpellier I, Montpellier (France);
- University of Namur – Belgium;
- Université de Pau et des Pays de L’Adour – Pau – France;
- CNRS and University of Strasbourg – Strasbourg – France;
- James Cook University – Townsville – Australia.
- Department of Natural Sciences, Bonn-Rhein-Sieg University (Germany);
- Institute for Genetics, University of Cologne (Germany);
- Department of Chemistry, Technische Universitat Berlin (Germany);
- Department of Systems Biology, Technical University of Denmark (Denmark);
- Institute of Microbiology/Biotechnology, University of Tubingen (Germany);
- Department of Gastroenterology, Catholic University of Leuven (Belgium);
- Merck Serono SA, Geneva (Switzerland);
- Hospital Mũniz of Buenos Aires (Argentina).
Inoltre è stata attivata sia una rete Italiana di dottorati nelle Scienze Biomediche e Biotecnologiche (NEIDOS, sito web: http://www.neidos.it/), che una rete Europea di dottorati in Scienze Farmaceutiche (European Paul Ehrlich MedChem PhD in Pharmaceutical Sciences, sito web: www.pehrlichmedchem.eu.) costituita dai corsi di Dottorati di venticinque Università appartenenti a quindici diversi Paesi Europei. La collaborazione tra Università Europee ha promosso ed incoraggiato il miglioramento del bagaglio culturale e l’addestramento alla ricerca dei dottorandi per far loro ottenere un titolo di Dottore di Ricerca meglio spendibile in Europa.
The research activities of the PhD students are analyzed and developed through collaborations with national and international research companies.The PhD course in Molecular and Biomolecular Sciences benefits of the following international collaborations:
- Institute for Experimental Oncology, Freiburg (Germania);
- University of Nottingham (UK);
- Istituto Nazionale dei Tumori Milano
- School of Pharmacy – University of Cardiff (UK);
- School of Pharmacy – University of London (UK);
- Semmelweis University – Budapest, Hungary; Pazmany Peter Catholic University – Budapest, Hungary;
- Université de Lyon, France.
- Institut des Biomolécules Max Mousseron CNRS UMR 5247, UFR Pharmacie - Université Montpellier I, Montpellier (France).
- University of Namur – Belgium,
- Université de Pau et des Pays de L’Adour – Pau – France;
- CNRS and University of Strasbourg – Strasbourg – France;
- James Cook University – Townsville – Australia.
- Department of Natural Sciences, Bonn-Rhein-Sieg University (Germany);
- Institute for Genetics, University of Cologne (Germany);
- Department of Chemistry, Technische Universitat Berlin (Germany);
- Department of Systems Biology, Technical University of Denmark (Denmark);
- Institute of Microbiology/Biotechnology, University of Tubingen (Germany);
- Department of Gastroenterology, Catholic University of Leuven (Belgium);
- Merck Serono SA, Geneva (Switzerland);
- Hospital Mũniz of Buenos Aires (Argentina).
Moreover, it has been activated both an Italian network of PhD Programs in Biomedical and Biotechnological Sciences (NEIDOS, website: http://www.neidos.it/), and an European network of PhD programs in Pharmaceutical Sciences (European Paul Ehrlich Med Chem PhD in Pharmaceutical Sciences, website: www.pehrlichmedchem.eu). Such collaborations has promoted and improved the cultural baggage and the training of PhD students with the aim of obtaining degree recognized anywhere in Europe.